Michael Hurwitz, MD, PhD

Michael Hurwitz, MD, PhD, is a medical oncologist who cares for people with genitourinary cancers, including kidney, bladder, prostate, and testicular cancers. He uses immune cell-based therapies to treat a wide range of solid tumors.

“As a clinician, my goal is to provide the best clinical care to my patients,” Dr. Hurwitz says. “To do that, I think it is paramount to address patients’ goals and desires.”

As an associate professor of medicine (medical oncology) at Yale School of Medicine, Dr. Hurwitz focuses on expanding clinical trials for immune cell-based treatments. He collaborates with scientists to develop new approaches for improving outcomes in kidney and other solid tumor cancers. He is also the co-director of the Cell Therapy Clinical Research Program at Yale Cancer Center.

Dr. Hurwitz received his medical degree from Cornell University Medical College and earned a doctoral degree from Rockefeller University. He completed a residency in internal medicine at The NewYork-Presbyterian Hospital/Weill Cornell Medical Center, followed by a fellowship in adult oncology at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Massachusetts General Hospital.